Rituximab Is an Efficient and Safe Treatment in Adults With Steroid-Dependent Minimal Change Disease

Kidney International - United States
doi 10.1038/ki.2012.444
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Elsevier BV

Related search

1522 Evidence of Chronic Renal Damage in Patients With Steroid Dependent Minimal Change Disease (Mcd) Nephrotic Syndrome

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Rituximab Therapy for Focal Segmental Glomerulosclerosis and Minimal Change Disease in Adults: A Systematic Review and Meta-Analysis

BMC Nephrology
Nephrology
2020English

Treatment Patterns and Steroid Dose for Adult Minimal Change Disease Relapses: A Retrospective Cohort Study

PLoS ONE
Multidisciplinary
2018English

IgA Nephropathy With Minimal Change Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

Interstitial Lung Disease in Patients With Scleroderma: Treatment With Rituximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Steroid Treatment in Children With Sickle-Cell Disease

Haematologica
Hematology
2007English

Minimal Change Disease Associated With High-Dose Aspirin

Cureus
2018English

Regional Intra-Arterial Steroid Treatment in 120 Patients With Steroid-Resistant or -Dependent GvHD

Bone Marrow Transplantation
TransplantationHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy